BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12432559)

  • 1. A case-control analysis of lymphocytic chromosome 9 aberrations in lung cancer.
    Zhu Y; Spitz MR; Strom S; Tomlinson GE; Amos CI; Minna JD; Wu X
    Int J Cancer; 2002 Dec; 102(5):536-40. PubMed ID: 12432559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung carcinoma patients with a family history of cancer and lymphocyte primary chromosome 9 aberrations.
    Wu X; Dave BJ; Jiang H; Pathak S; Spitz MR
    Cancer; 1997 Apr; 79(8):1527-32. PubMed ID: 9118034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescent in situ hybridization analysis in blood lymphocytes of lung cancer patients.
    Dave BJ; Risin SA; Spitz MR; Pathak S
    Anticancer Res; 1996; 16(3A):1187-92. PubMed ID: 8702234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer.
    Shao L; Lerner SL; Bondaruk J; Czerniak BA; Zeng X; Grossman HB; Spitz MR; Wu X
    Genes Chromosomes Cancer; 2004 Dec; 41(4):379-89. PubMed ID: 15390184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrations Involving Chromosome 1 as a Possible Predictor of Odds Ratio for Colon Cancer--Results from the Krakow Case-Control Study.
    Galas A; Miszczyk J
    PLoS One; 2016; 11(1):e0147658. PubMed ID: 26824604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer.
    Wei Q; Gu J; Cheng L; Bondy ML; Jiang H; Hong WK; Spitz MR
    Cancer Res; 1996 Sep; 56(17):3975-9. PubMed ID: 8752166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions.
    Wu X; Lippman SM; Lee JJ; Zhu Y; Wei QV; Thomas M; Hong WK; Spitz MR
    Cancer Res; 2002 May; 62(10):2813-8. PubMed ID: 12019158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer.
    Wu X; Zhao Y; Honn SE; Tomlinson GE; Minna JD; Hong WK; Spitz MR
    Cancer Res; 1998 Apr; 58(8):1605-8. PubMed ID: 9563468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer.
    Hazra A; Grossman HB; Zhu Y; Luo S; Spitz MR; Wu X
    Genes Chromosomes Cancer; 2004 Dec; 41(4):330-8. PubMed ID: 15390186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzo(a)pyrene diol epoxide-induced chromosome 9p21 aberrations are associated with increased risk of bladder cancer.
    Gu J; Horikawa Y; Chen M; Dinney CP; Wu X
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2445-50. PubMed ID: 18768515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of cells with bleomycin-induced chromosomal lesions in the cultured lymphocytes of lung cancer patients.
    Wu XF; Spitz MR; Delclos GL; Connor TH; Zhao Y; Siciliano MJ; Hsu TC
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):527-32. PubMed ID: 8827357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic susceptibility to lung cancer as determined by lymphocytic chromosome analysis.
    Dave BJ; Hopwood VL; King TM; Jiang H; Spitz MR; Pathak S
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):743-9. PubMed ID: 8672991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BPDE-induced lymphocytic 3p21.3 aberrations may predict head and neck carcinoma risk.
    Zhu Y; Spitz MR; Zheng YL; Hong WK; Wu X
    Cancer; 2002 Aug; 95(3):563-8. PubMed ID: 12209748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokinesis-blocked micronucleus cytome assay and spectral karyotyping as methods for identifying chromosome damage in a lung cancer case-control population.
    Lloyd SM; Lopez M; El-Zein R
    Genes Chromosomes Cancer; 2013 Jul; 52(7):694-707. PubMed ID: 23630028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome 5 aberrations and genetic predisposition to lung cancer.
    Wu X; Zhao Y; Kemp BL; Amos CI; Siciliano MJ; Spitz MR
    Int J Cancer; 1998 Oct; 79(5):490-3. PubMed ID: 9761118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of complex chromosomal aberrations in patients with myelodysplastic syndromes using multiplex fluorescence in situ hybridization combined with whole chromosome painting].
    Chen LJ; Li JY; Xiao B; Zhu Y; Liu Q; Pan JL; Qiu HR; Fan L; Zhang SJ; Lu RN; Xu W; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):635-9. PubMed ID: 18067073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting.
    Ramsey MJ; Moore DH; Briner JF; Lee DA; Olsen La; Senft JR; Tucker JD
    Mutat Res; 1995 Oct; 338(1-6):95-106. PubMed ID: 7565886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relations of the c-myc gene and chromosome 8 in non-small cell lung cancer: analysis by fluorescence in situ hybridization.
    Kubokura H; Tenjin T; Akiyama H; Koizumi K; Nishimura H; Yamamoto M; Tanaka S
    Ann Thorac Cardiovasc Surg; 2001 Aug; 7(4):197-203. PubMed ID: 11578259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Numerical abnormalities of chromosome 9 and p16CDKN2A gene deletion detected by FISH in non-small cell lung cancer.
    Panani AD; Maliaga K; Babanaraki A; Bellenis I
    Anticancer Res; 2009 Nov; 29(11):4483-7. PubMed ID: 20032395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a familial small supernumerary marker chromosome in a patient with adult-onset tongue cancer.
    Bakshi SR; Dave BJ; Sanger W; Brahmbhatt MM; Trivedi PJ; Kakadia PM; Patel SJ
    Cytogenet Genome Res; 2008; 121(1):14-7. PubMed ID: 18544921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.